A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

Oncogenes and signal transduction

Cantley, L. C., Auger, K. R., Carpenter, C. F., Duckworth, B. C., Graziani, A., Kapeller, R., & Soltoff, S. P. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,697

Growth Factors and Cancer

Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,017

Growth factor signaling by receptor tyrosine kinases

Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,418

RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS

Carpenter, G. F. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004313 · Cited by 1,282

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

Morrison, J. F. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90420-3 · Cited by 815

Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

Sandgren, E. P., Luetteke, N., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752

TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas

Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., & Merlino, G. T. (1990) · Cell · doi:10.1016/0092-8674(90)90076-q · Cited by 709

DIOGENES SYNDROME

Clark, A. N. G., Mankikar, G. D., & Gray, I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91280-5 · Cited by 697

EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS

Neal, D. E., Bennett, M., Hall, R. R., Marsh, C., Abel, P., Sainsbury, J. R. C., & Harris, A. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91386-8 · Cited by 604

Growth Inhibition of Human Tumor Cells in Athymic Mice by Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies

Masui, H., Kawamoto, T., Sato, J., Wolf, B., SATO, G. H., & Mendelsohn, J. M. (1984) · The Journal of Urology · doi:10.1016/s0022-5347(17)50005-1 · Cited by 446

Differential Regulation of EGF-like Growth Factor Genes in Human Keratinocytes

Stoll, S. W., & Elder, J. T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1654 · Cited by 17

Protein kinase inhibitors for the treatment of cancer

Patrick, D. R., & Heimbrook, D. C. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)10030-1 · Cited by 17

Cytoskeletal and Morphological Changes Associated with the Specific Suppression of the Epidermal Growth Factor Receptor Tyrosine Kinase Activity in A431 Human Epidermoid Carcinoma

Nelson, J. M., & Fry, D. W. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3571 · Cited by 17

PARs in the stars: proteinase-activated receptors and astrocyte function. Focus on “Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways”

Hollenberg, M. D. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00304.2002 · Cited by 17

A short and unequivocal synthesis of 5‐aminotetrazolo[1,5‐a]‐quinazoline as a tricyclic analogue of 4‐(3‐bromoanilino)‐6,7‐dimethoxyquinazoline (PD 153035)

Bouey-Bencteux, E., & Houssin, R. (1997) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570340447 · Cited by 17

HB‐EGF promotes progenitor cell proliferation and sensory neuron regeneration in the zebrafish olfactory epithelium

Sireci, S., Kocagöz, Y., Alkiraz, A. S., Güler, K., Dokuzluoglu, Z., Balcioglu, E., Meydanli, S., Demirler, M. C., Söğünmez, N., & Fuss, S. H. (2023) · FEBS Journal · doi:10.1111/febs.17033 · Cited by 17

6‐Aryl and Heterocycle Quinazoline Derivatives as Potent EGFR Inhibitors with Improved Activity toward Gefitinib‐Sensitive and ‐Resistant Tumor Cell Lines

Hamed, M. M., Ella, D. A. A. E., Keeton, A. B., Piazza, G. A., Abadi, A., Hartmann, R. W., & Engel, M. (2013) · ChemMedChem · doi:10.1002/cmdc.201300147 · Cited by 16

Preparation and Evaluation of 99mTc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors

Zhao, X., Wang, N., Ren, X.-C., Zhang, J., Wang, J., Han, J., Jia, L., Liu, Y., & Zhang, Z. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.136101 · Cited by 16

Strategies to Overcome Acquired Resistances Conferred by Mutations in the Kinase Domain of Egfr

Lim, S. M., Jeong, Y., & Hong, S. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0019 · Cited by 16

PI3K Inhibitors of Novel Hydrazide Analogues Linked 2-Pyridinyl Quinazolone Scaffold as Anticancer Agents

Zeid, I., Mohamed, N. A., Khalifa, N. M., Kassem, E. M. M., Nossier, E. S., Salman, A. A., Mahmoud, K. M., & Al-Omar, M. A. (2019) · Journal of Chemistry · doi:10.1155/2019/6321573 · Cited by 16

Antitumor and antileishmanial evaluation of novel heterocycles derived from quinazoline scaffold: a molecular modeling approach

Fleita, D. H., Mohareb, R. M., & Sakka, O. K. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0213-9 · Cited by 16

The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation

Forbes, K. A., Skinner, L., Aplin, J., & Westwood, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1067-5 · Cited by 16

Synthesis and antitumor activity of novel 6,7,8-trimethoxy N-aryl-substituted-4-aminoquinazoline derivatives

Liu, F., Huai, Z., Xia, G., Song, L., Li, S., Xu, Y., Hong, K., Yao, M., Liu, G., & Huang, Y. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.033 · Cited by 16

Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function

Montgomery, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10560 · Cited by 16

FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tract

Zhang, D., Kosman, J., Carmean, N., Grady, R. W., & Bassuk, J. A. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00025.2006 · Cited by 16

Protein Tyrosine Kinase Inhibitors as Therapeutic Agents

Levitzki, A. (2000) · Topics in current chemistry · doi:10.1007/3-540-45035-1_1 · Cited by 16

Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions

Kyo, S., Takakura, M., Tanaka, M., Kanaya, T., & Inoue, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1 · Cited by 51

Selective Inhibition of Platelet-Derived Growth Factor (PDGF) Receptor Autophosphorylation and PDGF-Mediated Cellular Events by a Quinoline Derivative

Yagi, M., Kato, S., Kobayashi, Y., Kubo, K., Oyama, S., Shimizu, T., Nishitoba, T., Isoe, T., Nakamura, K., Ohashi, H., et al. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3616 · Cited by 16

A one-pot synthetic approach for the construction of a thiazolo[3,2- a ]benzimidazole-linked quinazoline scaffold via palladium-catalyzed reactions

Keivanloo, A., Soozani, A., Bakherad, M., & Amin, A. H. (2018) · Organic Chemistry Frontiers · doi:10.1039/c7qo00751e · Cited by 15

Stimulatory roles of epidermal growth factor receptor (EGFR) in ovarian development of mud crab Scylla paramamosain

Lu, B., Jiang, Q., Liu, A., Huang, H., & Ye, H. (2020) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2020.113616 · Cited by 15

Drug targets in inflammation and immunomodulation

Buckle, D. R., & Hedgecock, C. J. R. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01074-x · Cited by 14

Contractile Action of Ethanol in Guinea Pig Gastric Smooth Muscle: Inhibition by Tyrosine Kinase Inhibitors and Comparison with the Contractile Action of Epidermal Growth Factor-Urogastrone

Zheng, X., Mokashi, S., & Hollenberg, M. D. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36792-8 · Cited by 15

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868

Simpson, B. J. B., Bartlett, J. M. S., Macleod, K. G., Rabiasz, G. J., Miller, E. P., Rae, A. L., Gordge, P. C., LEAKE, R. E., Miller, W. R., Smyth, J., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690175 · Cited by 15

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor

Högnäsbacka, A., Poot, A. J., Vugts, D. J., van Dongen, G. A. M. S., & Windhorst, A. D. (2022) · Pharmaceuticals · doi:10.3390/ph15040450 · Cited by 14

Advances in Cancer Chemotherapeutic Drug Research in China

Xu, B., Ding, J., Chen, K., Miao, Z., Huang, H., Liu, H., & Luo, X. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397833-2.00012-1 · Cited by 14

The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro

Samén, E., Thorell, J.-O., Fredriksson, A., & Stone‐Elander, S. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.09.008 · Cited by 14

Therapeutic and Preventive Effects of an Epidermal Growth Factor Receptor Inhibitor on Oral Squamous Cell Carcinoma

Ge, H., Liu, H.-G., Fu, Z., & Sun, Z. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000207 · Cited by 14

Design, Synthesis and Molecular Docking of Novel Quinazolinone Hydrazide Derivatives as EGFR Inhibitors

Fang, Z.-Y., Zhang, Y., Chen, C., Zheng, Q., Lv, P., Ni, L., Sun, J., & Wu, Y. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200189 · Cited by 14

Activation of EGFR/MEK/ERK/AP-1 signaling mediated by 1,2-naphthoquinone, an atmospheric electrophile, in human pulmonary A549 cells

Beei, C., Iwamoto, N., Inaba, T., Shinkai, Y., & Kumagai, Y. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.793 · Cited by 14

Recent patents on therapeutic applications of the transcription factor decoy approach

Gambari, R. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.629605 · Cited by 14

Enzyme Inhibition and Inactivation

Silverman, R. B., Xue, F., & Juncosa, J. I. (2004) · Elsevier eBooks · doi:10.1016/b978-0-08-051337-9.50010-9 · Cited by 14

S ignal T ransducers and A ctivators of T ranscription: I nsights into the M olecular B asis of O ral C ancer

Siavash, H., Nikitakis, N. G., & Sauk, J. J. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500505 · Cited by 14

Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase

Asano, T., Yoshikawa, T., Nakamura, H., Uehara, Y., & Yamamoto, Y. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.001 · Cited by 14

Elucidating inhibitory models of the inhibitors of epidermal growth factor receptor by docking and 3D-QSAR

Chen, G., Luo, X., Zhu, W., Luo, C., Liu, H. S., Puah, C. M., Chen, K., & Jiang, H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.02.001 · Cited by 14

Cyclic Peptides as Probes of the Substrate Binding Site of the Cytosolic Tyrosine Kinase, pp60c-src

McMurray, J. S., Budde, R. J. A., Ke, S., Obeyesekere, N., Wang, W., Ramdas, L., & Lewis, C. A. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0707 · Cited by 14

Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells

Hagmann, W., & Borgers, S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00833-7 · Cited by 14

Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.

Taetle, R., Santos, B. D., Akamatsu, K., Koishihara, Y., & Ohsugi, Y. (1996) · PubMed · Cited by 14

Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis

Murugesan, S., Jayakumar, M., Seedevi, P., Sivasankar, P., Murugan, T., Siddiqui, S. S., & Loganathan, S. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666201009130008 · Cited by 14

Magnetically Separable Fe3O4@poly(m‐phenylenediamine)@Cu2O Nanocatalyst for the Facile Synthesis of 5‐phenyl‐[1,2,3]triazolo[1,5‐c]quinazolines

Rawat, M., Taniike, T., & Rawat, D. S. (2022) · ChemCatChem · doi:10.1002/cctc.202101926 · Cited by 13

Role of the Non-Receptor Tyrosine Kinase Fes in Cancer

Condorelli, F., Stec‐Martyna, E., Zaborowska, J., Felli, L., Gnemmi, I., Ponassi, M., & Rosano, C. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796150522 · Cited by 13

Synthesis and In Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase

Mphahlele, M. J., Paumo, H. K., & Choong, Y. S. (2017) · Pharmaceuticals · doi:10.3390/ph10040087 · Cited by 13

THE CONTRIBUTION OF SYNTHETIC ORGANIC CHEMISTRY TO ANTICANCER DRUG DEVELOPMENT

Denny, W. A. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50012-7 · Cited by 13

Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.

Deb, T. B., Coticchia, C. M., Barndt, R. J., Zuo, H., Dickson, R., & Johnson, M. (2008) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00449.2007 · Cited by 14

F84, a quinazoline derivative, exhibits high potent antitumor activity against human gynecologic malignancies

Li, J., Meng, Y., Liu, Y., Feng, Z., & Chen, X. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9225-9 · Cited by 13

Efficient dual treatment of the hormone-refractory prostate cancer cell line DU145 with cetuximab and 1,25-dihydroxyvitamin D3.

Belochitski, O., Ariad, S., Shany, S., Fridman, V., & Gavrilov, V. (2007) · PubMed · Cited by 13

Tyrosine kinase effects on adrenoceptor-stimulated cyclic AMP accumulation in preoptic area and hypothalamus of female rats: modulation by estradiol

Quesada, A., & Etgen, A. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02052-7 · Cited by 13

Selective Inhibition of Receptor Tyrosine Kinases by Synthetic Analogues of Aeroplysinin

Waldmann, H., Hinterding, K., Herrlich, P. A., Rahmsdorf, H. J., & Knebel, A. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199715411 · Cited by 13

New Synthetic Route to Tetracyclic Quinazolin-4(3H)-one Ring System

Kim, K., & Mohanta, P. K. (2002) · Heterocycles · doi:10.3987/com-02-9508 · Cited by 13

External and internal EGFR-activating signals drive mammary epithelial cells proliferation and viability

Morato, A., Martignani, E., Miretti, S., Baratta, M., & Accornero, P. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111081 · Cited by 12

Mechanotransduction in the Lung Cyclic stretch activates ERK1/2 via G proteins and EGFR in alveolar epithelial cells

Correa-Meyer, E., Pesce, L. M., Guerrero, C., & Sznajder, J. I. (2002) · Cited by 12

Skin Cancer Prevention

Lluria-Prevatt, M., Dickinson, S. E., & Alberts, D. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_13 · Cited by 13

Potent Cardioprotective Effect of the 4-Anilinoquinazoline Derivative PD153035: Involvement of Mitochondrial KATP Channel Activation

Cavalheiro, R. A., Marin, R. M., Rocco, S. A., Cerqueira, F. M., da Silva, C. C. C., Rittner, R., Kowaltowski, A. J., Vercesi, A. E., Franchini, K. G., & Castilho, R. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010666 · Cited by 12

Translocation of fibroblast growth factor‐10 and its receptor into nuclei of human urothelial cells

Kosman, J., Carmean, N., Leaf, E. M., Dyamenahalli, K., & Bassuk, J. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21330 · Cited by 12

8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src Kinase Inhibitors

Berger, D. M., Dutia, M. D., Powell, D. W., Wu, B., Wissner, A., DeMorin, F., Weber, J. M., & Boschelli, F. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00524-3 · Cited by 12

Regulation of TGF-α-induced activation of AP-1 in the aging gastric mucosa

Xiao, Z.-Q., Li, J., & Majumdar, A. P. N. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00530.2002 · Cited by 12

Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targets

Lai, J. Y. Q., Langston, S., Adams, R., Beevers, R. E., Boyce, R., Burckhardt, S., Cobb, J. M., Ferguson, Y., Figueroa, E., Grimster, N. P., et al. (2004) · Medicinal Research Reviews · doi:10.1002/med.20026 · Cited by 12

Simple, Selective, and Practical Synthesis of 2-Substituted 4(3H)-Quinazolinones by Yb(OTf)3-Catalyzed Condensation of 2-Aminobenzamide with Carboxamides

Kondo, T., Yoshimura, T., Yuanjun, D., Kimura, Y., Yamada, H., & Toshimitsu, A. (2014) · Heterocycles · doi:10.3987/com-14-s(k)79 · Cited by 12

In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches

Simond, A. M., & Muller, W. J. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.04.004 · Cited by 12

HER-2-directed, small-molecule antagonists.

Arkin, M. R., & Moasser, M. M. (2008) · PubMed · Cited by 12

Upregulation of retinoic acid receptor‐β by the epidermal growth factor‐receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways

Grunt, T. W., Tomek, K., Wagner, R., Puckmair, K., Kainz, B., Rünzler, D., Gaiger, A., Köhler, G., & Zielinski, C. C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20990 · Cited by 12

A role for endogenous TGF? and associated signaling pathways in the differentiation of lens fiber cells

Chen, F., Mrock, L. K., & Ireland, M. E. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200002)186:2 · Cited by 11

Design, antiproliferative potency, and in silico studies of novel 5-methylfuran-3-yl)thio)-3-phenylquinazolin-4(3H)-one based derivatives as potential EGFR inhibitors

Soliman, S. M., Abdel‐Rahman, A. A. ‐., Nossier, E. S., Hussein, M. F., Sabry, A., & El-Hema, H. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-12140-1 · Cited by 11

Novel pyrimidopyridothiazine based derivatives as potential anticancer and antibacterial agents: A step towards design and synthesis of multi-targeted therapeutics

El-Hema, H. S., Mady, M. F., Abdel‐Rahman, A. A. ‐., Nossier, E. S., El-Sayed, A. F., Sabry, A., El-Feky, M., & Hawata, M. A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143790 · Cited by 11

Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor requires E-cadherin in esophageal cancer and malignant pleural mesothelioma.

Xin, H., Yang, J. H., & Nguyen, D. M. (2013) · PubMed · Cited by 11

AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9

Ma, L., Yan, H., & Zhou, Q. (2014) · Oncology Letters · doi:10.3892/ol.2014.2224 · Cited by 11

Synthesis and biological assay of erlotinib analogues and BSA-conjugated erlotinib analogue.

Boobalan, R., Liu, K.-K., Chao, J.-I., & Chen, C.-P. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.059 · Cited by 9

Extracellular epimorphin modulates epidermal differentiation signals mediated by epidermal growth factor receptor

Okugawa, Y., & Hirai, Y. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.11.006 · Cited by 12

Tyrosine Kinase Inhibitors Against EGF Receptor-Positive Malignancies

Sudbeck, E. A., Ghosh, S., Liu, X., Zheng, Y., Myers, D. E., & Uckun, F. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-114-0:193 · Cited by 11

A study concerning the synthesis, basicity and hydrolysis of 4‐amino‐2‐(N,N‐diethylamino)quinazoline derivatives

Zieliński, W., & Kudelko, A. (2002) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570390627 · Cited by 11

7‐Substituted‐[1, 4]dioxano[2, 3‐g]quinazolines as Inhibitors of Epidermal Growth Factor Receptor Kinase

Lee, J. Y., Park, Y. K., Seo, S. H., Yang, B., Park, H., & Lee, Y. S. (2002) · Archiv der Pharmazie · doi:10.1002/ardp.200290003 · Cited by 11

Active site labelling of inositol 1,4,5-trisphosphate 3-kinase A by phenylglyoxal

Communi, D., Lecocq, R., Vanweyenberg, V., & Erneux, C. (1995) · Biochemical Journal · doi:10.1042/bj3100109 · Cited by 11

Quantitative image analysis of cellular protein translocation induced by magnetic microspheres: Application to the EGF Receptor

Brock, R. E., & Jovin, T. M. (2003) · Cytometry Part A · doi:10.1002/cyto.a.10024 · Cited by 11

Apoptosis and growth inhibition of head and neck tumor cell line induced by epidermal growth factor receptor tyrosine kinase inhibitor

Faust, R. A., Tawfic, S. H., Davis, A. T., & Ahmed, K. (1999) · Oral Oncology · doi:10.1016/s1368-8375(98)00118-3 · Cited by 11

Design, synthesis and characterization of “clickable” 4-anilinoquinazolinekinase inhibitors

Perera, B. G. K., & Maly, D. J. (2008) · Molecular BioSystems · doi:10.1039/b720014e · Cited by 10

Maximizing the Benefits of Off-Target Kinase Inhibitor Activity

Brewer, M. R., & Pao, W. J. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0581 · Cited by 10

Kinase Inhibitors in Cancer

Mortlock, A. A., Foote, K. M., Kettle, J. G., & Aquila, B. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.11033-9 · Cited by 13

Epidermal Growth Factor Receptor Ligands and Tumor Necrosis Factor‐α Coregulate Chemokine Expression in Human Keratinocytes

Pastore, S., Mascia, F., Mariani, V., & Girolomoni, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04634.x · Cited by 10

A fluorescent reporter of ATP binding-competent receptor kinases

Sicard, R., Dhuguru, J., Liu, W., Patel, N., Landgraf, R., & Wilson, J. N. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.034 · Cited by 10

Tyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells

Grunt, T. W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00512-8 · Cited by 10

Microwave Assisted Aza‐Wittig Reactions of N‐Imidoyliminophosphorane with Aldehydes: A Convenient and Selective Route to Quinazolines

Kumar, V., Sharma, A., & Mahajan, M. P. (2004) · Synthetic Communications · doi:10.1081/scc-120027237 · Cited by 10

Protein kinase inhibitors--potential chemotherapeutic agents.

Shugar, D. (1995) · Acta Biochimica Polonica · doi:10.18388/abp.1995_4894 · Cited by 10

Epidermal growth factor induces an increase in cell adhesion and an arrangement of actin skeleton in stress fibres in pituitary cultured cells from infantile rats but not adult rats

Toral, C., Solano‐Agama, M. C., Luna, J., Romano, M. C., & Mendoza‐Garrido, M. E. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10231 · Cited by 10

Minireview: Drug Discovery Using Receptors that Modulate Gene Expression

Lamb, P., & Rosen, J. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036626 · Cited by 10

Design, synthesis, and biological evaluation of novel amidoxime or amidine analogues of some 4-anilino-6,7-dimethoxyquinazolines with a potent EGFR inhibitory effect

Acar, C., Göker, H., Kütük, Ö., Çeli̇k, İ., & Altuntas, T. G. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108345 · Cited by 9

Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer

Fozing, T., Scheuer, C., & Samnick, S. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.05.027 · Cited by 9

Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer

Yang, L., Liu, S., Chu, J., Miao, S., Wang, K., Zhang, Q., Wang, Y., Xiao, Y., Lina, W., Liu, Y., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm00293c · Cited by 9

Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells

Longo, A., Librizzi, M., Chuckowree, I., Baltus, C. B., Spencer, J., & Luparello, C. (2015) · Molecules · doi:10.3390/molecules20069879 · Cited by 9

Evaluation of radioiodinated quinazoline derivative as a new ligand for EGF receptor tyrosine kinase activity using SPECT

Hirata, M., Kanai, Y., Naka, S., Matsumuro, K., Kagawa, S., Yoshimoto, M., & Ohmomo, Y. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-010-0432-4 · Cited by 9

Simple and straight forward synthesis of 2,4-disubstituted quinazolines in aqueous medium

Madhav, B., Sabbavarapu, N. M., Pavan, A. K. B. S., Akula, A. K., & Durga, N. Y. V. (2012) · European Journal of Chemistry · doi:10.5155/eurjchem.3.2.252-257.527 · Cited by 9

An Affinity‐Based, Cysteine‐Specific ATP Analog for Kinase‐Catalyzed Crosslinking

Fouda, A. E., Gamage, A. K., & Pflum, M. K. H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202014047 · Cited by 9

Disruptin, a cell-penetrating peptide degrader of EGFR

Mehta, R. K., Shukla, S., Ramanand, S. G., Somnay, V., Bridges, A. J., Lawrence, T. S., & Nyati, M. K. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101140 · Cited by 10

Tyrosine protein kinase assays

Boutin, J. A. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00563-3 · Cited by 9

Expression of heregulin by mouse mammary tumor cells: Role in activation of ErbB receptors

Schmitt, M., Walker, M. P., Richards, R. G., Bocchinfuso, W. P., Fukuda, T., Medina, D., Kittrell, F. S., Korach, K. S., & DiAugustine, R. P. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20180 · Cited by 9

Rapid microwave‐assisted cleavage of methyl phenyl ethers: new method for synthesizing desmethyl precursors and for removing protecting groups

Fredriksson, A., & Stone‐Elander, S. (2002) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.577 · Cited by 9

Design, synthesis, molecular docking, and evaluation of sulfonyl quinazoline analogues as promising liver cancer drugs

Venkatesan, G., Ping, C. Y., Chen, H., Perumal, S., Karkhanis, A. V., & Pastorin, G. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107777 · Cited by 8

A useful EGFR-TK ligand for tumor diagnosis with SPECT: development of radioiodinated 6-(3-morpholinopropoxy)-7-ethoxy-4-(3′-iodophenoxy)quinazoline

Hirata, M., Kanai, Y., Naka, S., Yoshimoto, M., Kagawa, S., Matsumuro, K., Katsuma, H., Yamaguchi, H., Magata, Y., & Ohmomo, Y. (2013) · Annals of Nuclear Medicine · doi:10.1007/s12149-013-0703-y · Cited by 8

Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics

Bronchud, M. H., Brizuela, L., Gyuris, J., & Mansuri, M. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_11 · Cited by 8

ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478

Luk, P. P., Galettis, P., & Links, M. J. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.12.016 · Cited by 8

BML-265 and Tyrphostin AG1478 Disperse the Golgi Apparatus and Abolish Protein Transport in Human Cells

Boncompain, G., Gareil, N., Tessier, S., Lescure, A., Jones, T. R., Kepp, O., Kroemer, G., Nery, E. D., & Perez, F. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00232 · Cited by 8

PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.

Bos, M., Mendelsohn, J. M., Kim, Y. M., Albanell, J., Fry, D. W., & Baselga, J. M. (1997) · PubMed · Cited by 199

Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice

Kunkel, M. W., Hook, K. E., Howard, C. T., Przybranowski, S. A., Roberts, B. J., Elliott, W. L., & Leopold, W. R. (1995) · Investigational New Drugs · doi:10.1007/bf00873135 · Cited by 59

Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Rae, J. M., & Lippman, M. E. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010702.10130.29 · Cited by 29

Cytoskeletal and Morphological Changes Associated with the Specific Suppression of the Epidermal Growth Factor Receptor Tyrosine Kinase Activity in A431 Human Epidermoid Carcinoma

Nelson, J. M., & Fry, D. W. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3571 · Cited by 17

Biochemical and antiproliferative properties of 4-[Ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor

Fry, D. W., Nelson, J. M., Slintak, V., Keller, P. R., Rewcastle, G. W., Denny, W. A., Zhou, H., & Bridges, A. J. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00242-6 · Cited by 65